Latest Breaking News On - Xianjun xu - Page 1 : comparemela.com

SAN DIEGO, Nov. 13, 2023 Gyre Therapeutics , a clinical-stage biotechnology company developing anti-fibrotic therapeutics for a variety of chronic liver diseases, today announced the.

United statesSan diegoStephen jasperCharles wuXianjun xuDepartment of gastroenterologyCatalyst biosciences incContinent pharmaceuticals ltdMedicines product administration of chinaShanghai jiao tong university school of medicineAmerican associationLiver diseasePannual liver meetingMetabolic dysfunction associated steatohepatitisChief executive officerTumor growth transforming